Signs of recovery from Alzheimer’s dementia, and other neurological disorders are being shown by patients on plasmalogen and other targeted-nutrient therapies. Plasmalogen is a phospholipid essential to brain, lung, and heart function.
These patients first had their biochemical imbalances pinpointed using neuroscientist Dr. Dayan Goodenowe’s diagnostic technology. They were then given plasmalogen and other nutrient treatments based on their needs.
Dr. Goodenowe identifies low plasmalogen as the prime cause of Alzheimer’s disease, as well as a leading cause of amyotrophic lateral sclerosis (also known as ALS, or Lou Gehrig’s disease), autism, and other neurological disorders.
“What I discovered and invented is a means of making targeted plasmalogen precursors that can go to specific cell types for specific cell purposes,” says Dr. Goodenowe.

Posted in

Iron Will

Leave a Comment

You must be logged in to post a comment.